Cardionet, which provides real-time outpatient management solutions for monitoring an individual's cardiac health, announced terms for its IPO in a filing with the SEC on Thursday. The company plans to offer a total of 6.6 million shares, 3.6 million from selling shareholders, at a range of $22 to $24. Citi is the lead manager on the deal, which is expected to price during the third week of March.
